Liraglutide: The First GLP-1 Generic Referencing Victoza

1 year ago

By: Mazal Borukhova, PharmD Candidate c/o 2026, Jacqueline Demirjian, PharmD Candidate c/o 2029, Alicia Lumia, PharmD Candidate c/o 2029, Hailey…

The Effect of Adderall in Healthy College Students

1 year ago

By: Sumaiya Chowdhury, PharmD Candidate c/o 2026, Daniyal Khan, PharmD Candidate c/o 2027, Wajiha Uddin, PharmD Candidate c/o 2027 &…

The Utilization of Real World Evidence in Pediatric Drug Approvals

1 year ago

By: Sharupa Azmal, PharmD Candidate c/o 2026, Sarah El-Rowmeim, PharmD Candidate c/o 2027, Akhila Ajith Kumar, PharmD Candidate c/o 2027,…

Interview with Dr. Aaron Muth

1 year ago

By: Rosa Kang PharmD Candidate c/o 2027 Dr. Aaron Muth, Ph.D., is currently an Associate Professor in the Department of…

How Political Changes Are Reshaping the Pharmaceutical Industry in 2025

1 year ago

By: Nivaj Haque PharmD Candidate c/o 2027 The pharmaceutical industry is undergoing significant changes in the background as new government…

FDA Approves First Oral Liquid Imatinib for Certain Cancers

1 year ago

By Amanda Nakhul, Biomedical Sciences c/o 2027 Precision is key in multiple aspects of our lives, including medicine. Diseases such…

FDA Approves New Schizophrenia Drug with New Mechanism of Action

1 year ago

By Ansha Hamid PharmD Candidate c/o 2027 Schizophrenia is a severe mental illness that is described by a list of…

The FDA’s Red Dye No. 3 Ban: Its Far-reaching Impact on Public Health, Pharmacies, and the Pharmaceutical Industry

1 year ago

By: Sariah Grant PharmD Candidate c/o 2027 Color additives have long played a crucial role in the appearance and appeal…

FDA Approval of Landiolol (Rapiblyk) for Supraventricular Tachycardia

2 years ago

By: Nivaj Haque; PharmD Candidate c/o 2027 Recent advancements in cardiology have revolutionized the management of arrhythmias, offering new hope…

What is the best price to use for pharmacoeconomic purposes?

2 years ago

By: Farzana Alam, PharmD Candidate c/o 2025, Anthony Autera, PharmD Candidate c/o 2025, Maha Saad, PharmD Background Drug pricing metrics…